Toggle light / dark theme

Peter Diamandis Describes How Applying AI to Drug Discovery is Causing Positive Disruption to Biopharma

The content of Peter’s email blast has been edited by me (can’t help myself). But I believe I have captured its essence and hope you enjoy the retelling. As always your comments are welcomed.

What is Insilico Medicine?

Insilico Medicine is a pioneering drug company that is powered by a “drug discovery engine” that sifts through millions of data samples to determine the signature biological characteristics of specific diseases. It then identifies the most promising treatment targets and uses a new AI technique called generative adversarial networks (GANs) to create molecules perfectly suited against them.

The 3G shutdown will affect everyday devices you probably own

The looming shutdown of 3G networks won’t just impact older phones.

With AT&T’s 3G network shutting down next week, and other carriers following suit later this year, a range of products require updates to continue working, including some home alarm systems, medical devices such as fall detectors, and in-car crash notification and roadside assistance systems such as General Motors’ OnStar.

Just as many mobile carriers have urged customers to swap their older 3G iPhones, Android phones, e-readers and other handheld devices for newer models ahead of the shutdown, other businesses are urging customers to upgrade or replace some of the everyday products and services in their homes and cars before they drop connectivity.

Progress, Potential, and Possibilities

Progress, Potential, And Possibilities has had another busy month! — Come subscribe & enjoy all of our fascinating guest who are creating a better tomorrow! #Health #Longevity #Biotech #Space #AI #Technology #Medicine #Entertainment #Energy #Regeneration #Environment #Sustainability #Food #Innovation #Future #Defense #STEM #Aging #IraPastor


Interviews and Discussions With Fascinating People Who are Creating A Better Tomorrow For All Of Us — Host — Ira S. Pastor.

Hypertonic saline solution with furosemide infusion may be beneficial in fluid overload in patients with reduced ejection fraction

Background: Diuretic-resistant fluid overload is a common problem encountered in hospitalized heart failure (HF) patients, with different interventions proposed to overcome it. Some studies have suggested that combining hypertonic saline with furosemide provided advantages over furosemide alone.

Study design: Systematic review and meta-analysis.

Setting: A comprehensive search of several databases from each database’s inception to March 17, 2020, and reference lists of retrieved articles and review articles in the field to identify additional publications.

Applications of the amniotic membrane in tissue engineering and regeneration: the hundred-year challenge

The amniotic membrane (Amnio-M) has various applications in regenerative medicine. It acts as a highly biocompatible natural scaffold and as a source of several types of stem cells and potent growth factors. It also serves as an effective nano-reservoir for drug delivery, thanks to its high entrapment properties. Over the past century, the use of the Amnio-M in the clinic has evolved from a simple sheet for topical applications for skin and corneal repair into more advanced forms, such as micronized dehydrated membrane, amniotic cytokine extract, and solubilized powder injections to regenerate muscles, cartilage, and tendons. This review highlights the development of the Amnio-M over the years and the implication of new and emerging nanotechnology to support expanding its use for tissue engineering and clinical applications. Graphical Abstract.

Disentangling Interactions Across Brain Areas

Summary: Feedforward and feedback signaling involves different neural activity patterns. The findings shed new light on how the brain processes visual information.

Source: Carnegie Mellon University.

Exploring how brain areas communicate with each other is the focus of a long-standing research collaboration between Carnegie Mellon University, Albert Einstein College of Medicine, and Champalimaud Research.

Inside Mark Zuckerberg’s plan to cure all diseases as he reveals views on death

BILLIONAIRE Mark Zuckerberg has revealed his thoughts on life and death in a recent podcast.

The Facebook founder and Meta Platforms CEO has plans to cure all diseases this century but has no desire to live forever.

Zuckerberg hasn’t had an ordinary life.

He founded Facebook when he was just 19 years old and became the youngest billionaire at just 23.

/* */